SARS-CoV-2 and probable lung cancer risk

被引：6
|
作者：
Khiali, Sajad [1 ]
Rezagholizadeh, Afra [1 ]
Entezari-Maleki, Taher [1 ,2 ]
机构：
[1] Tabriz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Cardiovasc Res Ctr, Tabriz, Iran
来源：
BIOIMPACTS | 2022年 / 12卷 / 03期
关键词：
COVID-19; SARS-CoV-2; Oncovirus; Lung cancer; Lung fibrosis; INFLAMMATION;
D O I：
10.34172/bi.2022.23266
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global crisis with a growing number of mortalities and morbidities worldwide. Despite performing numerous researches, there are still considerable unrevealed details regarding the long-term complications and post-infection immunity of the coronavirus disease 2019 (COVID-19). Based on pathophysiological features, SARS-CoV-2 may act similarly as an oncovirus in the lung. This letter summarized three possible oncogenic mechanisms of SARS-CoV-2 that may be associated with lung cancer development.
引用
收藏
页码：291 / 292
页数：2
相关论文
共 50 条
  • [21] Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study
    Provencio, Mariano
    Rodriguez-Abreu, Delvys
    Ortega, Ana L.
    Serrano, Gloria
    Aguado, Carlos
    Franco, Fernando
    Gutierrez, Vanesa
    Lopez Vivanco, Guillermo
    Guirado, Maria
    Benitez, Gretel
    Estival, Anna
    Calvo, Virginia
    Jimenez, Beatriz
    Arasanz, Hugo
    Coves, Juan
    Majem, Margarita
    Massuti, Bartomeu
    Vazquez, Sergio
    Juan-Vidal, Oscar
    Collazo-Lorduy, Ana
    Gozalvez, Clara L.
    Del Barco, Edel
    Rosero, Adriana
    Bosch-Barrerra, Joaquim
    Moreno, Maria A.
    Mielgo-Rubio, Xavier
    Villa, Jose C.
    Lopez-Martin, Ana
    Cordoba, Juan F.
    de Asis Aparisi, Francisco
    Zafra, Marta
    Mosquera, Joaquin
    Perez Altozano, Javier
    Nadal, Ernest
    Catot, Silvia
    Balsalobre, Jose
    de Portugal, Teresa
    Martin, Paloma
    Cuesta de Juan, Susana
    Cobo, Manuel
    TRANSLATIONAL LUNG CANCER RESEARCH, 2022, 11 (01) : 53 - +
  • [22] Antirheumatic in SARS-CoV-2: benefit or risk?
    Ferrara, Francesco
    ITALIAN JOURNAL OF MEDICINE, 2020, 14 (02) : 114 - 115
  • [23] SARS-CoV-2 and Risk to Food Safety
    Anelich, Lucia E. C. M.
    Lues, Ryk
    Farber, Jeffrey M.
    Parreira, Valeria R.
    FRONTIERS IN NUTRITION, 2020, 7
  • [24] Impfung gegen SARS-CoV-2 bei KrebspatientenVaccination against SARS-CoV-2 in cancer patients
    Marie von Lilienfeld-Toal
    Christina Rieger
    Nicola Giesen
    Bernhard Wörmann
    Der Onkologe, 2021, 27 : 691 - 696
  • [25] Management and outcome of EGFR mutant lung cancer with SARS-CoV-2 infection
    Kolluri, Spoorthy
    Panda, Soumya Surath
    Panda, Adyakinkar
    Singh, Santosh Kumar
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1454 - 1456
  • [26] Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset
    Morgan, Helen
    Gysling, Savannah
    Navani, Neal
    Baldwin, David
    Hubbard, Richard
    O'Dowd, Emma
    THORAX, 2024, 79 (01) : 83 - 85
  • [27] Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections
    Somisetty, Medha
    Mack, Philip C.
    Hsu, Chih-Yuan
    Huang, Yuanhui
    Gomez, Jorge E.
    Rodilla, Ananda M.
    Cagan, Jazz
    Tavolacci, Sooyun C.
    Carreno, Juan Manuel
    Brody, Rachel
    Moore, Amy C.
    King, Jennifer C.
    Rohs, Nicholas C.
    Rolfo, Christian
    Bunn, Paul A.
    Minna, John D.
    Bhalla, Sheena
    Krammer, Florian
    Garcia-Sastre, Adolfo
    Figueiredo, Jane C.
    Kazemian, Elham
    Reckamp, Karen L.
    Merchant, Akil A.
    Nadri, Maimoona
    Ahmed, Rafi
    Ramalingam, Suresh S.
    Shyr, Yu
    Hirsch, Fred R.
    Gerber, David E.
    CLINICAL LUNG CANCER, 2024, 25 (07) : 612 - 618
  • [28] SARS-CoV-2 and Lung Cancer: Pandemic Impact in Diagnosis, Staging and Management
    Tsukazan, M. T.
    Schneider, G. F.
    Bittencourt Hinrichsen, L.
    Iglesias, M.
    Schulze, P. A.
    Paulino, R.
    Menegaz, T.
    Vigo, A.
    Schmitt, J.
    Figueiredo Pinto, J.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1056 - S1057
  • [29] Microplastics dysregulate innate immunity in the SARS-CoV-2 infected lung
    Bishop, Cameron R.
    Yan, Kexin
    Nguyen, Wilson
    Rawle, Daniel J.
    Tang, Bing
    Larcher, Thibaut
    Suhrbier, Andreas
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [30] SARS-CoV-2 Infection and Cardioncology: From Cardiometabolic Risk Factors to Outcomes in Cancer Patients
    Quagliariello, Vincenzo
    Bonelli, Annamaria
    Caronna, Antonietta
    Conforti, Gabriele
    Iovine, Martina
    Carbone, Andreina
    Berretta, Massimiliano
    Botti, Gerardo
    Maurea, Nicola
    CANCERS, 2020, 12 (11) : 1 - 25
12345